COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,286 Articles (22,759 medRxiv, 8,527 bioRxiv)

Most recent first Previous |  Page 2530: Articles 25291-25300  | Next

Next-generation diagnostics: virus capture facilitates a sensitive viral diagnosis for epizootic and zoonotic pathogens including SARS-CoV-2
Wylezich, C., Calvelage, S., Schlottau, K., Ziegler, U., Pohlmann, A., Hoeper, D., Beer, M.
10.1101/2020.06.30.181446 — Posted: 2020-07-01
High affinity binding of SARS-CoV-2 spike protein enhances ACE2 carboxypeptidase activity
Lu, J., Sun, P. D.
10.1101/2020.07.01.182659 — Posted: 2020-07-01
periscope: sub-genomic RNA identification in SARS-CoV-2 ARTIC Network Nanopore Sequencing Data
Parker, M. D., Lindsey, B. B., Leary, S., Gaudieri, S., Chopra, A., Wyles, M., Angyal, A., Green, L. R., Parsons, P., Tucker, R. M., Brown, R., Groves, D., Johnson, K., Carrilero, L., Heffer, J., Partridge, D., Evans, C., Razza, M., Keeley, A. J., Smith, N., Wang, D., Mallal, S., de Silva, T. I.
10.1101/2020.07.01.181867 — Posted: 2020-07-01
SARS-CoV-2 reactive T cells in uninfected individuals are likely expanded by beta-coronaviruses
Stervbo, U., Rahmann, S., Roch, T., Westhoff, T. H., Babel, N.
10.1101/2020.07.01.182741 — Posted: 2020-07-01 Discussion: Onsite | Offsite
Quantifying the impact of US state non-pharmaceutical interventions on COVID-19 transmission
Korevaar, H. M., Becker, A. D., Miller, I. F., Grenfell, B. T., Metcalf, C. J. E., Mina, M. J.
10.1101/2020.06.30.20142877 — Posted: 2020-07-01
Real-world Experience with Favipiravir for Treatment of COVID-19 in Thailand: Results from a Multi-center Observational Study
Rattanaumpawan, P., Jirajariyavej, S., Lerdlamyong, K., Palavutitotai, N., Saiyarin, J.
10.1101/2020.06.24.20133249 — Posted: 2020-07-01
A simple, safe and sensitive method for SARS-CoV-2 inactivation and RNA extraction for RT-qPCR
Kalnina, L., Mateu-Regue, A., Oerum, S., Hald, A., Gerstoft, J., Oerum, H., Cilius Nielsen, F., Iversen, A. K. N.
10.1101/2020.06.29.179176 — Posted: 2020-07-01
Multicenter comparison of the Cobas 6800 system with the RealStar RT-PCR kit for the detection of SARS-CoV-2
Chaix, M.-L., Wirden, M., Feghoul, L., Bertine, M., Nere, M.-L., Le Hingrat, Q., Abdi, B., Boutolleau, D., Ferre, V. M., Jary, A., Delaugerre, C., Marcelin, A.-G., Descamps, D., LeGoff, J., Visseaux, B.
10.1101/2020.06.29.179184 — Posted: 2020-07-01
Phase 1/2 Study to Describe the Safety and Immunogenicity of a COVID-19 RNA Vaccine Candidate (BNT162b1) in Adults 18 to 55 Years of Age: Interim Report
Mulligan, M. J., Lyke, K. E., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S. P., Neuzil, K., Raabe, V., Bailey, R., Swanson, K. A., Li, P., Koury, K., Kalina, W., Cooper, D., Fonter-Garfias, C., Shi, P.-Y., Tuereci, O., Tompkins, K. R., Walsh, E. E., Frenck, R., Falsey, A. R., Dormitzer, P. R., Gruber, W. C., Sahin, U., Jansen, K. U.
10.1101/2020.06.30.20142570 — Posted: 2020-07-01 Discussion: Onsite | Offsite
A phenome-wide association study (PheWAS) of COVID-19 outcomes by race using the electronic health records data in Michigan Medicine
Salvatore, M., Gu, T., Mack, J. A., Prabhu Sankar, S., Patil, S., Valley, T. S., Singh, K., Nallamothu, B. K., Kheterpal, S., Lisabeth, L., Fritsche, L. G., Mukherjee, B.
10.1101/2020.06.29.20141564 — Posted: 2020-07-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).